Intramolecular Thioether Crosslinking of Therapeutic Proteins to Increase Proteolytic Stability

Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action

(2014) Odile E. Levy et al.   PLoS One

Inhaled proteins: Challenges and perspectives

(2013) Flore Depreter et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Approaches for enhancing oral bioavailability of peptides and proteins

(2013) Jwala Renukuntla et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule-Albumin-Binding Domain Fusion Protein

(2013) A. Orlova et al.   JOURNAL OF NUCLEAR MEDICINE

Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein delivery

(2012) Yeonhee Yun et al.   ADVANCED DRUG DELIVERY REVIEWS

Orally Active Peptidic Bradykinin B1 Receptor Antagonists Engineered from a Cyclotide Scaffold for Inflammatory Pain Treatment

(2012) Clarence T. T. Wong et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Chemical Macrocyclization of Peptides Fused to Antibody Fc Fragments

(2012) Alessandro Angelini et al.   BIOCONJUGATE CHEMISTRY

Liposomal delivery of proteins and peptides

(2012) Janani Swaminathan et al.   Expert Opinion on Drug Delivery

Nasal drug delivery — Recent developments and future prospects

(2012) Lisbeth Illum   JOURNAL OF CONTROLLED RELEASE

Development of α-Helical Calpain Probes by Mimicking a Natural Protein–Protein Interaction

(2012) Hyunil Jo et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Protease-Resistant Peptide Ligands from a Knottin Scaffold Library

(2011) Jennifer A. Getz et al.   ACS Chemical Biology

Synthesis and Activity of Thioether-Containing Analogues of the Complement Inhibitor Compstatin

(2011) Patrick J. Knerr et al.   ACS Chemical Biology

Engineering and Functionalization of the Disulfide-Constrained Miniprotein Min-23 as a Scaffold for Diagnostic Application

(2011) Frederic Zoller et al.   ChemMedChem

Introduction to current and future protein therapeutics: A protein engineering perspective

(2011) Paul J. Carter   EXPERIMENTAL CELL RESEARCH

The Chemistry of Cyclotides

(2011) David J Craik et al.   JOURNAL OF ORGANIC CHEMISTRY

Protein Instability and Immunogenicity: Roadblocks to Clinical Application of Injectable Protein Delivery Systems for Sustained Release

(2011) Wim Jiskoot et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain

(2010) Jan Terje Andersen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Modulating Oxytocin Activity and Plasma Stability by Disulfide Bond Engineering

(2010) Markus Muttenthaler et al.   JOURNAL OF MEDICINAL CHEMISTRY

Oral protein delivery: Current status and future prospect

(2010) Kyeongsoon Park et al.   REACTIVE & FUNCTIONAL POLYMERS

To protect peptide pharmaceuticals against peptidases

(2010) R. Rink et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Synthesis and chemoselective intramolecular crosslinking of a HER2-binding affibody

(2009) Torun Ekblad et al.   BIOPOLYMERS

Sortase-mediated protein ligation: an emerging biotechnology tool for protein modification and immobilisation

(2009) Thomas Proft   BIOTECHNOLOGY LETTERS

Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog

(2008) L. D. Kluskens et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Engineering of a femtomolar affinity binding protein to human serum albumin

(2008) A. Jonsson et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Protein therapeutics: a summary and pharmacological classification

(2007) Benjamin Leader et al.   NATURE REVIEWS DRUG DISCOVERY

Mutational analysis of the interaction between albumin-binding domain from streptococcal protein G and human serum albumin

(2002) Martin Linhult et al.   PROTEIN SCIENCE